Based on the request from the State Institution “Center for the Safety of Pharmaceutical Products under the Ministry of Health of the Republic of Uzbekistan,” No. 41-41/36-17332 dated September 14, 2026, and pursuant to Clause 18 of the Regulation on the Specifics of Labeling Medicines and Medical Devices Using Digital Identification средства, approved by Resolution No. 149 of the Cabinet of Ministers dated April 2, 2022, and Clause 25 of the Regulation on the Procedure for Conducting Post-Marketing Control of Pharmaceutical Products, approved by Resolution No. 628 of the Cabinet of Ministers dated October 4, 2024, the operator is suspending the introduction into circulation and circulation of the following medicinal product and production batch:
- Medicinal product name: Lambene, Solution for Injection, Solution A 2 mL, Solution B 1 mL, No. 3 (GTIN 04860125590062)
- Production batch number: 520625
- Expiration date: June 10, 2028
- Issuer: Representative Office of VEGAPHARM LLP (TIN: 207262273)
The suspension of introduction into circulation and circulation was carried out by “writing off” 10,096 labeling codes and affects the activities of 1,132 participants in the circulation of labeled goods.
▶️ Discuss in the community
Comments
Please sign in to leave a comment.